-
6m 25sPart 2 | Session 1 5 Trials That Will Change Your Practice With Dr Sohaib
-
6m 24sPart 2 | Session 2 4 Trials That Will Change Your Practice With Dr Di Biase
-
54sPart 3 | Session 1 Dr Bergonti: Pulsed-Field Ablation & Reasons to Research
-
1m 52sPart 3 | Session 2 Dr Bruce Wilkoff: Therapy Morbidity and Advice to Young Researchers
-
31sPart 3 | Session 3 Dr Carlo Pappone: Advice to Early-Career Electrophysiologists
-
28sPart 3 | Session 4 Dr Juan Caro Codon: Building a Team For Success
-
1m 33s
-
4m 23sPart 1 | Session 1 POTTER: Oesophageal Fistulae in Catheter Ablation Patients
-
4m 26sPart 1 | Session 2 AdaptResponse: AdaptivCRT® Algorithm in Synchronized LV Pacing
-
6m 49sPart 1 | Session 3 MANIFEST-PF: Real-world Experience of PFA in Commercial Practice
-
6m 26s
-
2m 38sPart 1 | Session 5 TEMPO-HCM: Extended ECG Monitoring in HCM
-
3m 37sPart 1 | Session 6 Conformable PVI Catheter for Pulmonary Vein Isolation
EHRA 23 - We are joined onsite by Prof Carlo Pappone (IRCCS Policlinico San Donato, IT) who outlines the key findings of the BRUGADA Randomized trial.
In a randomized controlled trial, 150 patients with Brugada syndrome were enrolled in to develop an evidence-based treatment for the condition. Patients were randomized in a 2:1 fashion to receive either catheter ablation treatment with an ICD, or an ICD alone to evaluate the effectiveness of epicardial ablation in reducing rates of sudden cardiac death.
Questions:
- What is the reasoning behind this study?
- What are the unmet needs in the treatment of Brugada Syndrome?
- What was the study design and patient population?
- What are the key findings?
- What could be the impact of these results on clinical practice?
- What further research is needed?
Recorded at EHRA 2023, Barcelona.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Featured Highlights
In these concise overviews, selected faculty provide their thoughts on the most impactful trials from EHRA 2023.
Part 3
Behind the Heart
Watch our Behind the Heart series to learn more about the personal perspectives of the investigators behind top trials in cardiovascular science.
Comments